- Home
- ZNTL vs HNNA Comparison
ZNTL vs HNNA Comparison
Compare ZNTL & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- HNNA
- Stock Information
- Founded
- ZNTL 2014
- HNNA 1989
- Country
- ZNTL United States
- HNNA United States
- Employees
- ZNTL N/A
- HNNA N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- HNNA Investment Managers
- Sector
- ZNTL Health Care
- HNNA Finance
- Exchange
- ZNTL Nasdaq
- HNNA Nasdaq
- Market Cap
- ZNTL 105.8M
- HNNA 98.7M
- IPO Year
- ZNTL 2020
- HNNA N/A
- Fundamental
- Price
- ZNTL $1.99
- HNNA $11.18
- Analyst Decision
- ZNTL Buy
- HNNA
- Analyst Count
- ZNTL 7
- HNNA 0
- Target Price
- ZNTL $8.46
- HNNA N/A
- AVG Volume (30 Days)
- ZNTL 784.9K
- HNNA 11.0K
- Earning Date
- ZNTL 08-06-2025
- HNNA 08-06-2025
- Dividend Yield
- ZNTL N/A
- HNNA 4.92%
- EPS Growth
- ZNTL N/A
- HNNA 56.56
- EPS
- ZNTL N/A
- HNNA 1.25
- Revenue
- ZNTL $26,865,000.00
- HNNA $35,816,000.00
- Revenue This Year
- ZNTL N/A
- HNNA N/A
- Revenue Next Year
- ZNTL N/A
- HNNA N/A
- P/E Ratio
- ZNTL N/A
- HNNA $8.95
- Revenue Growth
- ZNTL N/A
- HNNA 32.04
- 52 Week Low
- ZNTL $1.01
- HNNA $8.43
- 52 Week High
- ZNTL $5.44
- HNNA $13.88
- Technical
- Relative Strength Index (RSI)
- ZNTL 78.59
- HNNA 42.52
- Support Level
- ZNTL $1.55
- HNNA $10.49
- Resistance Level
- ZNTL $1.70
- HNNA $11.31
- Average True Range (ATR)
- ZNTL 0.12
- HNNA 0.64
- MACD
- ZNTL 0.05
- HNNA -0.04
- Stochastic Oscillator
- ZNTL 91.43
- HNNA 31.15
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About HNNA Hennessy Advisors Inc.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.